Impact of COVID-19 on prevalence of community pharmacies as CLIA-Waived facilities-Reference-Cited by-同舟云学术

Impact of COVID-19 on prevalence of community pharmacies as CLIA-Waived facilities

Published:2021-09 Issue:9 Volume:17 Page:1574-1578
ISSN:1551-7411
Container-title:Research in Social and Administrative Pharmacy
language:en
Short-container-title:Research in Social and Administrative Pharmacy

Author:

Klepser Nicklas S.,Klepser Donald G.^ORCID,Adams Jennifer L.,Adams Alex J.,Klepser Michael E.

Publisher

Elsevier BV

Subject

Pharmaceutical Science,Pharmacy

Reference26 articles.

1. Good laboratory practices for waived testing sites;Centers for Disease Control and Prevention CDC;MMWR; November,2015

2. Relax pharmacy regulations to help with COVID-19 testing and treatment. Mercatus Center. Published March 27, 2020. Accessed November 29, 2020. https://www.mercatus.org/publications/covid-19-crisis-response/relax-pharmacy-regulations-help-covid-19-testing-and-treatment.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors influencing Implementation of point-of-care testing for acute respiratory infectious diseases in community pharmacies: A scoping review using the Consolidated Framework for Implementation research;Research in Social and Administrative Pharmacy;2024-06

2. Pharmacy-based CLIA-waived testing in the United States: Trends, impact, and the road ahead;Research in Social and Administrative Pharmacy;2024-06

3. How to implement a “standard of care” regulatory model for pharmacists;Journal of the American Pharmacists Association;2024-05

4. Expanding Access to Patient Care in Community Pharmacies for Minor Illnesses in Washington State;ClinicoEconomics and Outcomes Research;2024-05

5. Sampling of healthcare professionals’ perspective on point-of-care technologies from 2019–2021: A survey of benefits, concerns, and development;PLOS ONE;2024-03-08